Ampio Pharm Analysis
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
Ampio Pharm is overvalued with Real Value of 0.21 and Hype Value of 0.24. The main objective of Ampio Pharm pink sheet analysis is to determine its intrinsic value, which is an estimate of what Ampio Pharm is worth, separate from its market price. There are two main types of Ampio Pharm's stock analysis: fundamental analysis and technical analysis.
The Ampio Pharm pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ampio Pharm's ongoing operational relationships across important fundamental and technical indicators.
Ampio |
Ampio Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.21. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ampio Pharm recorded a loss per share of 10.66. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 12th of September 2023. Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.The quote for Ampio Pharm is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Ampio Pharm please contact Michael Martino at 720 437 6500 or go to https://ampiopharma.com.Ampio Pharm Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ampio Pharm's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ampio Pharm or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Ampio Pharm is not yet fully synchronised with the market data | |
| Ampio Pharm has some characteristics of a very speculative penny stock | |
| Ampio Pharm has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ampio Pharm currently holds about 23.25 M in cash with (8.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. |
Ampio Pharm Upcoming and Recent Events
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Ampio Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 340.61 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ampio Pharm's market, we take the total number of its shares issued and multiply it by Ampio Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Ampio Pharm Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ampio Pharm insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ampio Pharm's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ampio Pharm insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Richard Giles over six months ago Acquisition by Richard Giles of 75000 shares of Ampio Pharm at 0.56 subject to Rule 16b-3 | ||
Michael Martino over a year ago Purchase by Michael Martino of 76890 shares of Ampio Pharm | ||
David Stevens over a year ago Purchase by David Stevens of 25000 shares of Ampio Pharm |
Ampio Pharm Outstanding Bonds
Ampio Pharm issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ampio Pharm uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ampio bonds can be classified according to their maturity, which is the date when Ampio Pharm has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| AMPHENOL P NEW Corp BondUS032095AH42 | View | |
| US032095AK70 Corp BondUS032095AK70 | View | |
| US032095AJ08 Corp BondUS032095AJ08 | View | |
| APH 22 15 SEP 31 Corp BondUS032095AL53 | View | |
| US032095AP67 Corp BondUS032095AP67 | View |
Ampio Pharm Predictive Daily Indicators
Ampio Pharm intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ampio Pharm pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Ampio Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Ampio Pharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ampio shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Ampio Pharm. By using and applying Ampio Pink Sheet analysis, traders can create a robust methodology for identifying Ampio entry and exit points for their positions.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Ampio Pharm to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |